摘要
目的:研究卵巢浆液性癌中CD44及CK18的表达及预后意义。方法:免疫组化法检测CD44及CK18蛋白在72例卵巢浆液性癌组织中的表达水平,分析其表达水平与卵巢癌临床病理指标的相关性。结果:CD44及CK18的阳性表达率分别为66.7%及100%。CD44阳性的肿瘤细胞呈团簇状分布于肿瘤组织中,这种表达模式在高级别浆液性癌中更明显。CK18表达与患者年龄、淋巴结转移有关(P分别为0.014及0.015);CD44、CK18表达与化疗效果、总生存期及无病生存期无关。卵巢浆液性癌中CD44、CK18表达无相关性。结论:CD44及CK18蛋白在卵巢浆液性癌组织中的表达能在一定程度上反映患者的预后,但与化疗效果及生存期无关。
Objective:To investigate the expression pattern and prognostic values of CD44 and CK18 in ovarian serous carcinoma. Methods:Immunohistochemical evaluation including CD44 and CK18 was performed in paraffin wax-embedded tissues of 72 cases of ovarian serous carcinoma. The expression and the relationship with clinical parameters of these markers were analyzed. Results:The positive rates were 66.7% for CD44 and 100% for CK18. Clusters of CD44^+ cells scattered in tumor tissue, and the expression pattern was more prominent in highgrade serous carcinoma. CK18 expression significantly correlated with age (P= 0. 014) and lymph node metastasis (P=0.015). CD44 and CK18 expression levels neither were correlated with chemotherapeutic effects and overall disease free survival time, nor showed any mutual relationship between each other. Conclusion: The expressions of CD44 and CK18 are correlate with the prognosis of ovarian serous carcinoma, but they are not satisfactory indicators for chemotherapeutic effects and survival time.
出处
《现代妇产科进展》
CSCD
北大核心
2016年第4期245-248,共4页
Progress in Obstetrics and Gynecology
基金
国家自然科学基金(No:81472430)
“国家重大科学仪器设备开发专项”项目(No:2013YQ03065108)